Anna Oleksiak: Anticoagulation In Real Life Challenges And Patient Oriented Decisions
Anna Oleksiak, Cardiologist at National Institute of Cardiology Stefan Cardinal Wyszyński – National Research Institute, shared a post on LinkedIn։
”During my stay in Lisbon I had a privilege to give a lecture for Polish cardiologists about ‘Anticoagulation in specific situations’ during special pre-ACVC event.
Anticoagulation in real life causes lot of dilemmas, and we are increasingly forced to make individualized decisions and move towards patient-oriented precise medicine.
With Christophe Vandenbriele we wrote last year one of the Association for Acute Cardio Vascular Care – ACVC Clinical Decision Making Toolkit chapters: 10.2 Managing anticoagulation in critically ill in specific situations, which includes i.e. bleeding on OAC, anticagulation and hemolysis during MCS, heparin-induced thrombocytopenia, and MV thrombosis.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers